ICU Management of COVID-19 vaccine-related myelin oligodendrocyte glycoprotein IgG-association encephalomyelitis

Authors

Andrew Vrtar, Oakland University William Beaumont School of Medicine Medical Student
Moshe Haddad, Beaumont Health Resident
Roy G. Soto, Beaumont Health

Document Type

Conference Proceeding

Publication Date

10-23-2022

Abstract

This is a 19 y.o. woman with a history of bipolar disorder admitted to the hospital for Myelin Oligodendrocyte Glycoprotein IgG-Associated Encephalomyelitis. She received her COVID-19 vaccination 5 days prior to symptom onset. Progressive quadriparesis and deteriorating mental status prompted evaluation for airway and medical management of dysautonomia. In this case presentation, we will discuss the diagnostic evaluation and management of Myelin Oligodendrocyte Glycoprotein IgG-Associated Encephalomyelitis, and the relationship between COVID-19 vaccination and central nervous system demyelination.

Comments

American Society of Anesthesiology Annual Meeting, New Orleans, LA, October 21-25, 2022.

Recommended Citation

Vrtar A, Haddad M, Soto R. ICU Management of COVID-19 vaccine-related myelin oligodendrocyte glycoprotein IgG-association encephalomyelitis. Presented at: American Society of Anesthesiology Annual Meeting; 2022 Oct 21-25; New Orleans, LA.